- Home
- AUTL vs SCM Comparison
AUTL vs SCM Comparison
Compare AUTL & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- SCM
- Stock Information
- Founded
- AUTL 2014
- SCM 2012
- Country
- AUTL United Kingdom
- SCM United States
- Employees
- AUTL N/A
- SCM N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- SCM Finance/Investors Services
- Sector
- AUTL Health Care
- SCM Finance
- Exchange
- AUTL Nasdaq
- SCM Nasdaq
- Market Cap
- AUTL 359.3M
- SCM 384.8M
- IPO Year
- AUTL 2018
- SCM 2012
- Fundamental
- Price
- AUTL $2.26
- SCM $13.25
- Analyst Decision
- AUTL Strong Buy
- SCM Hold
- Analyst Count
- AUTL 5
- SCM 1
- Target Price
- AUTL $9.32
- SCM $13.00
- AVG Volume (30 Days)
- AUTL 2.6M
- SCM 121.6K
- Earning Date
- AUTL 05-08-2025
- SCM 05-12-2025
- Dividend Yield
- AUTL N/A
- SCM 12.08%
- EPS Growth
- AUTL N/A
- SCM 26.74
- EPS
- AUTL N/A
- SCM 1.42
- Revenue
- AUTL $9,011,000.00
- SCM $103,691,042.00
- Revenue This Year
- AUTL $329.53
- SCM $1.85
- Revenue Next Year
- AUTL $191.73
- SCM $2.30
- P/E Ratio
- AUTL N/A
- SCM $9.30
- Revenue Growth
- AUTL N/A
- SCM N/A
- 52 Week Low
- AUTL $1.11
- SCM $11.19
- 52 Week High
- AUTL $5.00
- SCM $15.56
- Technical
- Relative Strength Index (RSI)
- AUTL 80.26
- SCM 49.72
- Support Level
- AUTL $1.19
- SCM $13.10
- Resistance Level
- AUTL $1.79
- SCM $13.30
- Average True Range (ATR)
- AUTL 0.13
- SCM 0.23
- MACD
- AUTL 0.08
- SCM -0.02
- Stochastic Oscillator
- AUTL 98.98
- SCM 45.53
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About SCM Stellus Capital Investment Corporation
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.